Related Experiment Video
Updated: Jan 22, 2026

Collecting Hair Samples for Hair Cortisol Analysis in African Americans
Published on: June 10, 2018
Upregulation of miR-130b Contributes to Risk of Poor Prognosis and Racial Disparity in African-American Prostate
Yutaka Hashimoto1,2, Marisa Shiina1,2, Pritha Dasgupta1,2
1Department of Urology, San Francisco VA Medical Center, San Francisco, California.
Abstract:
Prostate cancer incidence and mortality rates are higher in African-American (AA) than in European-American (EA) men. The main objective of this study was to elucidate the role of miR-130b as a contributor to prostate cancer health disparity in AA patients. We also determined whether miR-130b is a prognostic biomarker and a new therapeutic candidate for AA prostate cancer. A comprehensive approach of using cell lines, tissue samples, and the TCGA database was employed. We performed a series of functional assays such as cell proliferation, migration, invasion, RT2-PCR array, qRT-PCR, cell cycle, luciferase reporter, immunoblot, and IHC. Various statistical approaches such as Kaplan-Meier, uni-, and multivariate analyses were utilized to determine the clinical significance of miR-130b. Our results showed that elevated levels of miR-130b correlated with race disparity and PSA levels/failure and acted as an independent prognostic biomarker for AA patients. Two tumor suppressor genes, CDKN1B and FHIT, were validated as direct functional targets of miR-130b. We also found race-specific cell-cycle pathway activation in AA patients with prostate cancer. Functionally, miR-130b inhibition reduced cell proliferation, colony formation, migration/invasion, and induced cell-cycle arrest. Inhibition of miR-130b modulated critical prostate cancer-related biological pathways in AA compared with EA prostate cancer patients. In conclusion, attenuation of miR-130b expression has tumor suppressor effects in AA prostate cancer. miR-130b is a significant contributor to prostate cancer racial disparity as its overexpression is a risk factor for poor prognosis in AA patients with prostate cancer. Thus, regulation of miR-130b may provide a novel therapeutic approach for the management of prostate cancer in AA patients.
Insights
MicroRNA-130b (miR-130b) overexpression contributes to prostate cancer health disparities in African-American men, acting as a prognostic biomarker and potential therapeutic target. Inhibiting miR-130b shows tumor suppressor effects, offering a new treatment strategy.
Area of Science:
- Oncology
- Genetics
- Health Disparities
Background:
- Prostate cancer exhibits higher incidence and mortality rates in African-American (AA) men compared to European-American (EA) men, indicating significant health disparities.
- The specific molecular mechanisms driving these race-based differences in prostate cancer remain incompletely understood.
Purpose of the Study:
- To investigate the role of microRNA-130b (miR-130b) in contributing to prostate cancer health disparities observed in AA patients.
- To evaluate miR-130b as a potential prognostic biomarker and therapeutic target for AA prostate cancer.
Main Methods:
- Utilized a multi-pronged approach including cell lines, patient tissue samples, and The Cancer Genome Atlas (TCGA) database.
- Performed functional assays (proliferation, migration, invasion, cell cycle), molecular analyses (RT2-PCR array, qRT-PCR, immunoblot, IHC), and statistical methods (Kaplan-Meier, survival analyses).
Main Results:
- Elevated miR-130b levels correlated with race disparity, prostate-specific antigen (PSA) levels, and treatment failure in AA patients.
- miR-130b was identified as an independent prognostic biomarker for AA patients, directly targeting tumor suppressor genes CDKN1B and FHIT.
- Inhibition of miR-130b demonstrated tumor suppressor effects, reducing cancer cell proliferation, invasion, and inducing cell-cycle arrest, with race-specific pathway modulation observed.
Conclusions:
- miR-130b overexpression is a significant factor in prostate cancer racial disparity and a risk factor for poor prognosis in AA men.
- Attenuation of miR-130b exhibits tumor suppressor activity, suggesting its potential as a novel therapeutic target for managing prostate cancer in AA patients.
Related Concept Videos
Binet's Contribution to Measures of Intelligence
Relative Risk
Wechsler's Contribution to Measures of Intelligence
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Design Example: Analyzing Capacity Contours for Flood Risk Assessment
Cancer

